Skip to Content

  • Search

View Additional Section Content

A Placebo – Controlled, Double-Blind, Parallel-group, Bayesian Adaptive Randomization Design and Dose Regimen – finding Study To Evaluate Safety, Tolerability and Efficacy of BA2401 in Subjects with Early Alzheimer’s Disease.

For more information on this trial, click the link below.

https://clinicaltrials.gov/ct2/show/NCT01767311?term=nct01767311&rank=1

Clinical Trial Categories

  • Alzheimer's Disease
Contact
Jennifer McGowan at 215-327-0161

Location

  • Abington Neurological Associates, Ltd

Find a Physician
Search Our Directory

215-481-MEDI

Schedule a
Test

215-481-EXAM

Clinical Trials Details